The UK-based collaboration will include expertise across more than 40 types of cancer, with access to patients from more than 170 referring oncologists.
The clinical trial site network company's survey of participants offers information that could shed light on ways to improve recruitment and retention.
The two companies will work together to promote technology for at-home clinical research conducted in trials focused on developing respiratory therapies.
After receiving FDA approval, the pharmaceutical company has announced plans to launch a Phase I trial for an inhaled version of the COVID-19 treatment.
With its purchase of ADPM Wearable Technologies, the technology provider is looking to provide more cost-effective, efficient data gathering solutions.
The pharmaceutical company shares details from an ongoing trial looking into the effectiveness of a pair of drugs on treating triple-negative breast cancer.
